Detalhe da pesquisa
1.
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.
N Engl J Med;
2024 Jun 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38828984
2.
Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas.
Ann Surg Oncol;
2024 May 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38802717
3.
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian Cohort.
Ann Surg Oncol;
2024 May 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38762644
4.
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging.
Ann Surg Oncol;
31(3): 1857-1864, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37966706
5.
Genomic Profiling of Metastatic Basal cell Carcinoma Reveals Candidate Drivers of Disease and Therapeutic Targets.
Mod Pathol;
36(4): 100099, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36788083
6.
Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers.
Mod Pathol;
36(8): 100190, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37080394
7.
Modeling Methods in Craniofacial Virtual Surgical Planning.
J Craniofac Surg;
34(4): 1191-1198, 2023 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36806300
8.
Effect of operative time on complications associated with free flap reconstruction of the head and neck.
Clin Otolaryngol;
48(2): 175-181, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36321439
9.
Travel-associated cost savings to patients and the health system through provision of specialist head and neck surgery outreach clinics in rural New South Wales, Australia.
Aust J Rural Health;
31(5): 932-943, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37501345
10.
Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma Metastases.
Ann Surg Oncol;
29(11): 7019-7028, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35771368
11.
Benchmarking Survival Outcomes Following Surgical Management of pT3 and pT4 Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Ann Surg Oncol;
29(8): 5124-5138, 2022 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35419758
12.
Recursive Partitioning to Determine Order of Significance of Regional Metastasis Characteristics in Head and Neck Cutaneous Squamous Cell Carcinoma.
Ann Surg Oncol;
29(11): 6991-6999, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35569073
13.
Complex melanoma of the scalp: Diagnosis and management aided by confocal microscopy.
Australas J Dermatol;
63(1): 105-109, 2022 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34699066
14.
Utility of optical coherence tomography in basal cell naevus syndrome: A case report.
Australas J Dermatol;
63(4): e331-e335, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36125195
15.
Histological regression in melanoma: impact on sentinel lymph node status and survival.
Mod Pathol;
34(11): 1999-2008, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34247192
16.
Validation of the American Joint Committee on Cancer Staging in Squamous Cell Carcinoma of the Vermilion Lip.
Ann Surg Oncol;
28(6): 3092-3099, 2021 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33389299
17.
Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for Melanoma.
Ann Surg Oncol;
28(11): 6109-6123, 2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34347220
18.
Regional Metastasis in Head and Neck Cutaneous Squamous Cell Carcinoma: An Update on the Significance of Extra-Nodal Extension and Soft Tissue Metastasis.
Ann Surg Oncol;
27(8): 2840-2845, 2020 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32072378
19.
Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial.
Lancet Oncol;
20(7): 961-971, 2019 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31171444
20.
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.
Lancet Oncol;
20(7): 948-960, 2019 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31160251